New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis
暂无分享,去创建一个
Federico Perez | Daniel H. Haft | Derek M. Harkins | Michael R. Jacobs | Mark D. Adams | Robert A. Bonomo | M. Adams | D. Haft | R. Bonomo | K. Hujer | M. Wright | Michael F. Benard | M. Jacobs | D. Harkins | Meredith S. Wright | Kristine M. Hujer | Saralee Bajaksouzian | S. Bajaksouzian | F. Pérez
[1] R. Hall,et al. Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.
[2] Alessandra Carattoli,et al. Characterization and PCR-Based Replicon Typing of Resistance Plasmids in Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[3] Michelle G. Giglio,et al. TIGRFAMs and Genome Properties: tools for the assignment of molecular function and biological process in prokaryotic genomes , 2006, Nucleic Acids Res..
[4] R. Bonomo,et al. Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to Cefepime , 2011, Antimicrobial Agents and Chemotherapy.
[5] M. Adams,et al. The Success of Acinetobacter Species; Genetic, Metabolic and Virulence Attributes , 2012, PloS one.
[6] K. Kaye,et al. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] P. Visca,et al. Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. , 2011, Research in microbiology.
[8] Olivier Gascuel,et al. Fast and Accurate Phylogeny Reconstruction Algorithms Based on the Minimum-Evolution Principle , 2002, WABI.
[9] Evan S Snitkin,et al. Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii , 2011, Proceedings of the National Academy of Sciences.
[10] G. Smith,et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. , 2013, JAMA internal medicine.
[11] S. Amyes,et al. Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] E. Sužiedėlienė,et al. Novel Variants of AbaR Resistance Islands with a Common Backbone in Acinetobacter baumannii Isolates of European Clone II , 2012, Antimicrobial Agents and Chemotherapy.
[13] P. Courvalin,et al. Worldwide Disseminated armA Aminoglycoside Resistance Methylase Gene Is Borne by Composite Transposon Tn1548 , 2005, Antimicrobial Agents and Chemotherapy.
[14] Aaron A. Klammer,et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data , 2013, Nature Methods.
[15] S. Pournaras,et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. , 2013, International journal of antimicrobial agents.
[16] Eric P. Skaar,et al. Genomic and Functional Analysis of the Type VI Secretion System in Acinetobacter , 2013, PloS one.
[17] Daniel R Zerbino,et al. Using the Velvet de novo Assembler for Short‐Read Sequencing Technologies , 2010, Current protocols in bioinformatics.
[18] M. Adams,et al. Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii , 2008, Journal of bacteriology.
[19] L. Dijkshoorn,et al. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.
[20] S. Valdezate,et al. Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. , 2013, The Journal of antimicrobial chemotherapy.
[21] L. Dijkshoorn,et al. Horizontal Gene Transfer in a Polyclonal Outbreak of Carbapenem-Resistant Acinetobacter baumannii , 2006, Journal of Clinical Microbiology.
[22] S. Amyes,et al. Characterization of Epidemiologically Unrelated Acinetobacter baumannii Isolates from Four Continents by Use of Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Sequence-Based Typing of blaOXA-51-like Genes , 2010, Journal of Clinical Microbiology.
[23] A. Sundsfjord,et al. Dissemination of a Carbapenem-Resistant Acinetobacter baumannii Strain Belonging to International Clone II/Sequence Type 2 and Harboring a Novel AbaR4-Like Resistance Island in Latvia , 2012, Antimicrobial Agents and Chemotherapy.
[24] Thomas Ludwig,et al. RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees , 2005, Bioinform..
[25] P. Nordmann,et al. Genetic and Functional Variability of AmpC-Type β-Lactamases from Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[26] R. Bonomo,et al. Global Challenge of Multidrug-Resistant Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.
[27] Arjun Srinivasan,et al. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010 , 2013, Infection Control & Hospital Epidemiology.
[28] L. Rice,et al. Identification of a New Allelic Variant of the Acinetobacter baumannii Cephalosporinase , ADC-7-Lactamase : Defining a Unique Family of Class C Enzymes ‡ , 2005 .
[29] G. Weinstock,et al. High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. , 2010, The Journal of hospital infection.
[30] F. Blattner,et al. Mauve: multiple alignment of conserved genomic sequence with rearrangements. , 2004, Genome research.
[31] P. Nordmann,et al. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[32] J. Poulain,et al. Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles , 2008, PloS one.
[33] Christopher E. Jones,et al. Identification of Bacterial Protein O-Oligosaccharyltransferases and Their Glycoprotein Substrates , 2013, PloS one.
[34] Chuan Yi Tang,et al. The origin of Acinetobacter baumannii TYTH-1: a comparative genomics study. , 2013, International journal of antimicrobial agents.
[35] Daniel J. Wilson,et al. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance , 2012, BMJ Open.
[36] M. Kaufmann,et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. , 2006, FEMS microbiology letters.
[37] Paul Keim,et al. Evolution of a Pathogen: A Comparative Genomics Analysis Identifies a Genetic Pathway to Pathogenesis in Acinetobacter , 2013, PloS one.
[38] L. Munoz-Price,et al. Long-term acute care hospitals. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] Derrick E. Fouts,et al. PanOCT: automated clustering of orthologs using conserved gene neighborhood for pan-genomic analysis of bacterial strains and closely related species , 2012, Nucleic acids research.
[40] J. Weissenbach,et al. Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii , 2006, PLoS genetics.
[41] P. Visca,et al. Characterization of pABVA01, a Plasmid Encoding the OXA-24 Carbapenemase from Italian Isolates of Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.
[42] M. Adams,et al. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. , 2010, The Journal of antimicrobial chemotherapy.
[43] Nichollas E. Scott,et al. A common pathway for O‐linked protein‐glycosylation and synthesis of capsule in Acinetobacter baumannii , 2013, Molecular microbiology.
[44] Carol A. Keohane,et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. , 2013, JAMA internal medicine.
[45] G. Dougan,et al. Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology , 2012, PLoS pathogens.
[46] D. Ecker,et al. Longitudinal Analysis of the Temporal Evolution of Acinetobacter baumannii Strains in Ohio, USA, by Using Rapid Automated Typing Methods , 2012, PloS one.
[47] I. Paulsen,et al. A novel family of genomic resistance islands, AbGRI2, contributing to aminoglycoside resistance in Acinetobacter baumannii isolates belonging to global clone 2. , 2013, The Journal of antimicrobial chemotherapy.
[48] P. Higgins,et al. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[49] D. Ecker,et al. Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center , 2006, Antimicrobial Agents and Chemotherapy.
[50] J. Segre,et al. Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment , 2013, Genome research.
[51] Paolo Piazza,et al. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission , 2012, Genome Biology.
[52] Evan S Snitkin,et al. Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing , 2012, Science Translational Medicine.
[53] R. Hancock,et al. The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A , 2011, Antimicrobial Agents and Chemotherapy.
[54] P. Nordmann,et al. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species , 2011, IUBMB life.
[55] P. Nordmann,et al. AbaR-type transposon structures in Acinetobacter baumannii. , 2012, The Journal of antimicrobial chemotherapy.
[56] J. Claverie,et al. Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.
[57] P. Nordmann,et al. Functional Analysis of Insertion Sequence ISAba1, Responsible for Genomic Plasticity of Acinetobacter baumannii , 2009, Journal of bacteriology.
[58] Ramana Madupu,et al. CharProtDB: a database of experimentally characterized protein annotations , 2011, Nucleic Acids Res..
[59] L. Actis,et al. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. , 2003, Microbiology.
[60] R. Durbin,et al. Pfam: A comprehensive database of protein domain families based on seed alignments , 1997, Proteins.
[61] P. Courvalin,et al. Plasmid-Mediated High-Level Resistance to Aminoglycosides in Enterobacteriaceae Due to 16S rRNA Methylation , 2003, Antimicrobial Agents and Chemotherapy.
[62] R. Munson,et al. Acinetobacter baumannii Utilizes a Type VI Secretion System for Bacterial Competition , 2013, PloS one.
[63] Y. Carmeli,et al. Molecular and Epidemiologic Study of Polyclonal Outbreaks of Multidrug-Resistant Acinetobacter baumannii Infection in an Israeli Hospital , 2007, Infection Control & Hospital Epidemiology.
[64] M. Adams,et al. Genomewide Analysis of Divergence of Antibiotic Resistance Determinants in Closely Related Isolates of Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[65] Qing Yang,et al. Genomic Analysis of the Multidrug-Resistant Acinetobacter baumannii Strain MDR-ZJ06 Widely Spread in China , 2011, Antimicrobial Agents and Chemotherapy.
[66] G. Bou,et al. OXA-24 Carbapenemase Gene Flanked by XerC/XerD-Like Recombination Sites in Different Plasmids from Different Acinetobacter Species Isolated during a Nosocomial Outbreak , 2010, Antimicrobial Agents and Chemotherapy.
[67] M. Hamidian,et al. ISAba1 targets a specific position upstream of the intrinsic ampC gene of Acinetobacter baumannii leading to cephalosporin resistance. , 2013, The Journal of antimicrobial chemotherapy.
[68] Harald Seifert,et al. Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.
[69] P. Nordmann,et al. Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii1 , 2010, Emerging infectious diseases.
[70] Erin Beck,et al. The comprehensive microbial resource , 2000, Nucleic Acids Res..
[71] R. Hall,et al. Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes , 2013, PloS one.
[72] L. Dijkshoorn,et al. The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool , 2010, PloS one.
[73] Seth Schobel,et al. The Protein Naming Utility: a rules database for protein nomenclature , 2010, Nucleic Acids Res..